Seventeen women who met the criteria for bulimia nervosa (DSM-Ill-R) were treated for 4 weeks in an open trial with ipsapirone, a partial 5-HT,\* agonist. Bulimic symptoms diminished in 66.6% of the patients after only 7 week of treatment, 93.3% showed a reduction of more than 50% of weekly binge ea
A pilot, open clinical study of depakote in the treatment of cocaine abuse
β Scribed by James A. Halikas; Bruce A. Center; Victoria L. Pearson; Gregory A. Carlson; Fredrick Crea
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 171 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.252
No coin nor oath required. For personal study only.
β¦ Synopsis
The effectiveness of increasing levels of valproic acid on cocaine abstinence was evaluated in an open-label trial of 55 subjects. Significantly lower percentages of individuals with valproate serum levels above 50 mcg/ml reported cocaine use and had less positive urinalyses as compared to those with serum levels less than 50 mcg/ml. The total number of days of cocaine use decreased significantly (p < 0.001) and improved levels of subject functioning were found with increasing serum levels of valproic acid. This pilot study offers confirmation that the divalproex sodium form of valproic acid, when used in sufficient serum levels, may provide an effective pharmacologic adjunct in the management and treatment of cocaine dependency. Copyright 2001 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Background and objective: Various lasers have been suggested for cavity preparation. pain reduction is expected as a potential benefit of laser usage. among the systems studied in vitro, the er:yag laser offers a distinct combination of high ablation efficiency and low thermal side effects. anim
## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an openβlabel 12βweek trial of duloxetine 60βmg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal
## Abstract The objective of this study is to evaluate the tolerability and preliminary efficacy of levetiracetam (LEV) in reducing chorea in Huntington's disease (HD) patients in a prospective openβlabel pilot study. Nine HD patients with chorea were treated with LEV in doses up to 3,000 mg/day fo
The aim of this report is to show the results of a pilot, open label treatment programme for resistant schizophrenia in which risperidone was used before clozapine. Thirteen DSM I11 R, drug resistant schizophrenics were treated with risperidone p.0. at doses up to 16 mg/day for three months. Clinica